Reich Samuel J 4
4 · SAB Biotherapeutics, Inc. · Filed May 23, 2022
Insider Transaction Report
Form 4
Reich Samuel J
DirectorCEO
Transactions
- Other
Common Stock
2022-05-20−2,500,127→ 547,698 total(indirect: By LLC) - Other
Common Stock
2022-05-20+207,001→ 208,001 total
Footnotes (2)
- [F1]Pro rata distribution by Big Cypress Holdings LLC to its members for which no consideration is being paid in connection with such distribution. The Reporting Person is a managing member of Big Cypress Holdings LLC, and as part of the distribution will receive 207,001 shares of the issuer, which the Reporting Person previously had an indirect pecuniary interest.
- [F2]The Reporting Person received 207,001 shares as part of the distribution, which the Reporting Person previously had an indirect pecuniary interest. Therefore, the transaction, which only changes the form of the Reporting Person's ownership without increasing or decreasing his pecuniary interest, is exempt from the reporting requirements of Section 16 pursuant to Rule 16a-13. Notwithstanding, the Reporting Person is reporting the acquisition on a voluntary basis.